SCHEMBL685676

SCHEMBL685676

CCC(=O)OC(C)C(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
CYP2C19 P33261 1/20 0.38
RECQL P46063 1/20 0.38
KMT2A Q03164 1/20 0.38
ALOX15 P16050 1/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 2/20 0.35
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP3 P08254 1/20 0.35
MMP9 P14780 1/20 0.35
MMP13 P45452 1/20 0.35
ESR1 P03372 1/20 0.35
HIF1A Q16665 1/20 0.35
NAAA Q02083 1/20 0.33
TSHR P16473 1/20 0.32
TDP1 Q9NUW8 2/20 0.32
FFAR3 O14843 1/20 0.32
MGAM O43451 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24805426 0.89 MEN1 (0.41) MEN1CYP2C19RECQLKMT2AALOX15
SCHEMBL15186967 0.89 MEN1 (0.41) MEN1CYP2C19RECQLKMT2AALOX15
SCHEMBL25022295 0.85 MEN1 (0.36) MEN1CYP2C19RECQLKMT2AALOX15
SCHEMBL23249534 0.82 MEN1 (0.37) MEN1CYP2C19RECQLKMT2AALOX15
SCHEMBL12205685 0.82 MEN1 (0.37) MEN1CYP2C19RECQLKMT2AALOX15
SCHEMBL9730563 0.82 MEN1 (0.37) MEN1CYP2C19RECQLKMT2AALOX15
SCHEMBL15437903 0.81 MGAM (0.38) LMNAMMP1MMP2MMP3MMP9
SCHEMBL6790093 0.80 ESR1 (0.37) MEN1CYP2C19RECQLKMT2AALOX15
SCHEMBL14753124 0.80 ALDH1A1 (0.50) ALOX15ALDH1A1LMNATSHRFFAR3
SCHEMBL6892355 0.80 ALDH1A1 (0.50) ALOX15ALDH1A1LMNATSHRFFAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12509607-B2 Method for obtaining water-based paints using expanded polystyrene (EPS) waste and/or extruded polystyrene (XPS) waste as raw material ACUNA ROUGIER CRISTINA LUCIA (CL) 2025-12-30 US claimed
US-20230159784-A1 METHOD FOR OBTAINING WATER-BASED PAINTS USING EXPANDED POLYSTYRENE (EPS) WASTE AND/OR EXTRUDED POLYSTYRENE (XPS) WASTE AS RAW MATERIAL ACUNA ROUGIER CRISTINA LUCIA (CL) 2023-05-25 US claimed
EP-4140678-A1 METHOD FOR OBTAINING WATER-BASED PAINTS USING EXPANDED POLYSTYRENE (EPS) WASTE AND/OR EXTRUDED POLYSTYRENE (XPS) WASTE AS RAW MATERIAL Acuña Rougier, Cristina Lucía (CL) 2023-03-01 EP claimed
EP-3515971-B1 PROCESS FOR FABRICATION OF PAINTS BASED ON EXPANDED POLYSTYRENE (EPS) WASTE ACUNA ROUGIER CRISTINA LUCIA (CL) 2022-04-13 EP claimed
WO-2021212247-A1 METHOD FOR OBTAINING WATER-BASED PAINTS USING EXPANDED POLYSTYRENE (EPS) WASTE AND/OR EXTRUDED POLYSTYRENE (XPS) WASTE AS RAW MATERIAL ACUNA ROUGIER CRISTINA LUCIA (CL) 2021-10-28 WO claimed
US-20190338155-A1 PROCESS FOR FABRICATION OF PAINTS BASED ON EXPANDED POLYSTYRENE (EPS) WASTE ACUNA ROUGIER CRISTINA LUCIA (CL) 2019-11-07 US claimed
CN-109651148-A A kind of preparation method of 3- (1,2- dimethyl propylene oxygroup) propionic acid -1,2- dimethyl propyl ester 韶关市合众化工有限公司 2019-04-19 CN claimed
CN-104119718-A Water-in-oil type nitrocellulose colorful coating WUJIANG HUACHENG COMPOSITE MATERIAL SCIENCE & TECHNOLOGY CO LTD 2014-10-29 CN claimed
US-12509607-B2 Method for obtaining water-based paints using expanded polystyrene (EPS) waste and/or extruded polystyrene (XPS) waste as raw material ACUNA ROUGIER CRISTINA LUCIA (CL) 2025-12-30 US disclosed
WO-2025102184-A1 METHOD FOR PRODUCING COLLECTION DEVICES BASED ON RECYCLED RUBBER RESIXTEC SPA (CL) 2025-05-22 WO disclosed
US-20230357207-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS BCP3 PTY LIMITED (AU) 2023-11-09 US disclosed
US-20230159784-A1 METHOD FOR OBTAINING WATER-BASED PAINTS USING EXPANDED POLYSTYRENE (EPS) WASTE AND/OR EXTRUDED POLYSTYRENE (XPS) WASTE AS RAW MATERIAL ACUNA ROUGIER CRISTINA LUCIA (CL) 2023-05-25 US disclosed
US-20230150941-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT 2023-05-18 US disclosed
EP-4140678-A1 METHOD FOR OBTAINING WATER-BASED PAINTS USING EXPANDED POLYSTYRENE (EPS) WASTE AND/OR EXTRUDED POLYSTYRENE (XPS) WASTE AS RAW MATERIAL Acuña Rougier, Cristina Lucía (CL) 2023-03-01 EP disclosed
WO-2004110432-A1 ENALAPRIL-NITROXYDERIVATIVES DERIVATIVES AND RELATED COMPOUNDS AS ACE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES NICOX S.A. (FR) 2004-12-23 WO disclosed
EP-0409291-B1 Thermoplastic resin composition JAPAN SYNTHETIC RUBBER CO LTD (JP) 1996-02-14 EP disclosed
EP-0317262-B1 Transparent resin material JAPAN SYNTHETIC RUBBER CO LTD (JP) 1996-01-31 EP disclosed
US-5164469-A Substrate for optical disks, ring opening polymerization of tetracyclododecene derivatives JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1992-11-17 US disclosed
US-5053471-A Methathesis ring opening polymerization of polar substituted norbornenes or octahydromethanonphthalenes; optics JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1991-10-01 US disclosed
EP-0409291-A2 Thermoplastic resin composition JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1991-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150941-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS GABBR1, GABBR2, GABRE MEN1 1443/4885CYP2C19 69/4885RECQL 2096/4885
US-12509607-B2 Method for obtaining water-based paints using expanded polystyrene (EPS) waste and/or extruded polystyrene (XPS) waste as raw material RPS28, RPS27, RPS27L MEN1 4460/4885CYP2C19 3117/4885RECQL 603/4885
US-20230357207-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS MUC1, MPO, SERPINB1 MEN1 2553/4885CYP2C19 1952/4885RECQL 415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.